These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29754859)

  • 1. Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.
    Stenman M; Sinclair G; Paavola P; Wersäll P; Harmenberg U; Lindskog M
    Radiother Oncol; 2018 Jun; 127(3):501-506. PubMed ID: 29754859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.
    Meyer E; Pasquier D; Bernadou G; Calais G; Maroun P; Bossi A; Theodore C; Albiges L; Stefan D; de Crevoisier R; Hennequin C; Lagrange JL; Grellard JM; Clarisse B; Licaj I; Habrand JL; Carrie C; Joly F
    Eur J Cancer; 2018 Jul; 98():38-47. PubMed ID: 29864737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
    Kroeze SGC; Fritz C; Schaule J; Siva S; Kahl KH; Sundahl N; Blanck O; Kaul D; Adebahr S; Verhoeff JJC; Skazikis G; Roeder F; Geier M; Eckert F; Guckenberger M
    BJU Int; 2021 Jun; 127(6):703-711. PubMed ID: 33113260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma.
    Seastone DJ; Elson P; Garcia JA; Chao ST; Suh JH; Angelov L; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):111-6. PubMed ID: 24331575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.
    Ouzaid I; Capitanio U; Staehler M; Wood CG; Leibovich BC; Ljungberg B; Van Poppel H; Bensalah K;
    Eur Urol Oncol; 2019 Mar; 2(2):141-149. PubMed ID: 31017089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of stereotactic radiotherapy for metastases from renal cell carcinoma.
    Majewski W; Tabor M; Banaszek P; Glowacki G; Rokicki W; Tukiendorf A
    Neoplasma; 2016; 63(1):99-106. PubMed ID: 26639239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
    Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
    J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre.
    De Lichtenberg TH; Hermann GG; Rørth M; Højer Larsen MJ; Mansourvar Z; Holm ML; Scheike T
    Scand J Urol; 2014 Aug; 48(4):379-86. PubMed ID: 24521185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
    Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L
    Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Hsieh PY; Hung SC; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Cheng CL; Chiu KY
    Urol Oncol; 2021 Jul; 39(7):422-430. PubMed ID: 33934963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Brain metastases in renal cell carcinoma. Results of treatment and prognosis].
    Pomer S; Klopp M; Steiner HH; Brkovic D; Staehler G; Cabillin-Engenhart R
    Urologe A; 1997 Mar; 36(2):117-25. PubMed ID: 9199038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
    Thomas AZ; Adibi M; Slack RS; Borregales LD; Merrill MM; Tamboli P; Sircar K; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2016 Sep; 196(3):678-84. PubMed ID: 27036304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma.
    Liu Y; Zhang Z; Liu R; Wei W; Zhang Z; Mai L; Guo S; Han H; Zhou F; He L; Dong P
    Radiat Oncol; 2021 Nov; 16(1):211. PubMed ID: 34727963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.
    You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.